Armata Pharmaceuticals (ARMP) Receivables - Other (2022 - 2026)

Armata Pharmaceuticals has disclosed Receivables - Other across 5 years of filings, most recently posting $100000.0 for Q1 2026.

• Receivables - Other for Q1 2026 came in at $100000.0, down 50.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $100000.0 (down 50.0% YoY), and the FY2025 annual result was $500000.0, down 32.8% from the prior year.
• Receivables - Other came in at $100000.0 for Q1 2026 at Armata Pharmaceuticals, down from $500000.0 in the prior quarter.
• In the past five years, Receivables - Other ranged from a high of $7.4 million in Q2 2023 to a low of $100000.0 in Q1 2026.
• The 5-year median for Receivables - Other is $1.5 million (2023), against an average of $2.5 million.
• Across the five-year window, Receivables - Other slumped 89.86% in 2024 and jumped 194.12% in 2025, its largest moves.
• Armata Pharmaceuticals' Receivables - Other stood at $6.6 million in 2022, then tumbled by 77.26% to $1.5 million in 2023, then sank by 53.33% to $700000.0 in 2024, then declined by 28.57% to $500000.0 in 2025, then tumbled by 80.0% to $100000.0 in 2026.
• The last three Receivables - Other figures came in at $100000.0 (Q1 2026), $500000.0 (Q4 2025), and $2.2 million (Q2 2025), per Business Quant data.